Early Phase Cancer Immunotherapy: Current Cancer Research
Editat de Sandip Pravin Patel, Razelle Kurzrocken Limba Engleză Hardback – 10 noi 2017
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 984.57 lei 38-44 zile | |
| Springer International Publishing – 28 aug 2018 | 984.57 lei 38-44 zile | |
| Hardback (1) | 1103.95 lei 43-57 zile | |
| Springer International Publishing – 10 noi 2017 | 1103.95 lei 43-57 zile |
Din seria Current Cancer Research
- 5%
Preț: 1132.09 lei - 5%
Preț: 1609.56 lei - 5%
Preț: 728.66 lei - 5%
Preț: 1421.21 lei - 5%
Preț: 1094.08 lei - 5%
Preț: 1089.85 lei - 5%
Preț: 1481.57 lei - 5%
Preț: 1094.80 lei - 5%
Preț: 1447.73 lei - 5%
Preț: 706.97 lei - 5%
Preț: 1096.81 lei - 5%
Preț: 1098.48 lei - 5%
Preț: 1112.17 lei - 5%
Preț: 714.63 lei - 5%
Preț: 1297.22 lei - 5%
Preț: 1100.64 lei - 5%
Preț: 715.35 lei - 5%
Preț: 1171.03 lei - 5%
Preț: 902.44 lei - 5%
Preț: 1608.47 lei - 5%
Preț: 1438.78 lei
Preț: 1103.95 lei
Preț vechi: 1162.06 lei
-5% Nou
Puncte Express: 1656
Preț estimativ în valută:
211.26€ • 219.22$ • 176.58£
211.26€ • 219.22$ • 176.58£
Carte tipărită la comandă
Livrare economică 17-31 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319637563
ISBN-10: 3319637568
Pagini: 331
Ilustrații: XI, 331 p. 24 illus., 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.66 kg
Ediția:1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Seria Current Cancer Research
Locul publicării:Cham, Switzerland
ISBN-10: 3319637568
Pagini: 331
Ilustrații: XI, 331 p. 24 illus., 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.66 kg
Ediția:1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Seria Current Cancer Research
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins.- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy.- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies.- Chapter 4 Radiographic Evaluation of Immunotherapy.- Chapter 5 Cellular Therapy.- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation.- Chapter 7 Early Phase Cancer Immunotherapy.- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators.- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials.- Chapter 10 Thoracic Immunotherapy.
Notă biografică
Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science, Chief, Division of Hematology & Oncology, Murray Professor of Medicine, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California, San Diego.
Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.
Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.
Textul de pe ultima copertă
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Caracteristici
Focuses on a state-of-the-art review of early phase clinical trials for cancer immunotherapy Discusses about biomarker selection and combinatorial strategies Discusses about safety/toxicity determination of Phase 2 dosing, endpoints in the setting of psuedoprogession and histology selection as they relate to early phase cancer immunotherapy Features chapters written by internationally-known experts in the field